Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease
Top Cited Papers
- 1 March 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 5 (3), 519-530
- https://doi.org/10.2215/cjn.06080809
Abstract
In individuals with chronic kidney disease, high dietary phosphorus (P) burden may worsen hyperparathyroidism and renal osteodystrophy, promote vascular calcification and cardiovascular events, and increase mortality. In addition to the absolute amount of dietary P, its type (organic versus inorganic), source (animal versus plant derived), and ratio to dietary protein may be important. Organic P in such plant foods as seeds and legumes is less bioavailable because of limited gastrointestinal absorption of phytate-based P. Inorganic P is more readily absorbed by intestine, and its presence in processed, preserved, or enhanced foods or soft drinks that contain additives may be underreported and not distinguished from the less readily absorbed organic P in nutrient databases. Hence, P burden from food additives is disproportionately high relative to its dietary content as compared with natural sources that are derived from organic (animal and vegetable) food proteins. Observational and metabolic studies indicate nutritional and longevity benefits of higher protein intake in dialysis patients. This presents challenges to providing appropriate nutrition because protein and P intakes are closely correlated. During dietary counseling of patients with chronic kidney disease, the absolute dietary P content as well as the P-to-protein ratio in foods should be addressed. Foods with the least amount of inorganic P, low P-to-protein ratios, and adequate protein content that are consistent with acceptable palatability and enjoyment to the individual patient should be recommended along with appropriate prescription of P binders. Provision of in-center and monitored meals during hemodialysis treatment sessions in the dialysis clinic may facilitate the achievement of these goals.This publication has 58 references indexed in Scilit:
- Phosphorus and Potassium Content of Enhanced Meat and Poultry ProductsClinical Journal of the American Society of Nephrology, 2009
- Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKDJournal of the American Society of Nephrology, 2009
- Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young AdultsJournal of the American Society of Nephrology, 2009
- Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?The American Journal of Clinical Nutrition, 2008
- Phytate: impact on environment and human nutrition. A challenge for molecular breedingJournal of Zhejiang University-SCIENCE B, 2008
- Postprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKDJournal of the American Society of Nephrology, 2008
- Effects of Sevelamer and Calcium-Based Phosphate Binders on Lipid and Inflammatory Markers in Hemodialysis PatientsAmerican Journal of Nephrology, 2007
- Phosphorus-Containing Food Additives and the Accuracy of Nutrient Databases: Implications for Renal PatientsJournal of Renal Nutrition, 2007
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006
- Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemiaJournal of Renal Nutrition, 2004